NCT01773954View on ClinicalTrials.gov

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Age-Related Macular DegenerationMacular Degeneration
Interventions
DRUG

Intravitreal Aflibercept Injection

Increased or decreased time between visits

Trial Locations (3)

19006

Mid Atlantic Retina- Huntingdon Valley, Huntingdon Valley

19107

Mid Atlantic Retina- Wills Eye Institute, Philadelphia

08002

Mid Atlantic Retina- Cherry Hill, Cherry Hill

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

MidAtlantic Retina

OTHER

NCT01773954 - Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter